AC Immune SA - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ACIU Nasdaq 2836 www.acimmune.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AC Immune SA

Novo's Denecimig Gets CHMP Nod for Hemophilia A in the European Union - Sep 18th, 2026 10:09 am
XENE Files NDA for Epilepsy Drug, Falls on Depression Studies' Setback - Sep 18th, 2026 9:09 am
RARE Stock Up 13% on FDA Approval of Sanfilippo Syndrome Gene Therapy - Sep 18th, 2026 8:49 am
Kiniksa Pharmaceuticals Stock Rallies 41% in Three Months: Here's Why - Sep 17th, 2026 10:13 am
Novo Expands AI Push With Anthropic Deal to Accelerate Drug Discovery - Sep 17th, 2026 8:34 am
SION to Cut Workforce by Nearly Half After CF Study Failure, Stock Down - Sep 16th, 2026 9:26 am
Gilead Expands Lenacapavir Access With New PAHO Deal in Latin America - Sep 16th, 2026 8:26 am
GSK Inks $750M Deal to Add Experimental Blood Cancer Therapy - Sep 15th, 2026 9:22 am
Definium Reports Second Phase III Success in Anxiety Disorder Program - Sep 15th, 2026 8:16 am
GSK Presents Jideytro Data for Potential Use in First-Line NSCLC - Sep 14th, 2026 9:14 am
AbbVie's Atogepant Meets Goal in Late-Stage Menstrual Migraine Study - Sep 11th, 2026 8:22 am
Bayer Secures FDA Nod for Sevabertinib's First-Line Use in NSCLC - Sep 10th, 2026 10:05 am
Spyre's Anti-IL-23 Antibody Meets Goal in Ulcerative Colitis Study - Sep 9th, 2026 7:56 am
Verastem Stock Skyrockets 121% in 3 Months: Here Is Why - Sep 8th, 2026 8:09 am
CAPR Stock Skyrockets 144% in a Month: What Is Driving the Rally? - Sep 7th, 2026 7:28 am
SMMT Stock Soars on NSCLC Drug Survival Data Beating Keytruda in China - Sep 4th, 2026 8:37 am
IONS Secures FDA Nod for Rare Brain Disorder Drug Zanvastro - Sep 4th, 2026 7:18 am
Krystal Stock Gains 13.4% in a Month: What Is Driving the Rally? - Sep 3rd, 2026 9:49 am
FDA Accepts UTHR's sNDA for Tyvaso in Idiopathic Pulmonary Fibrosis - Sep 3rd, 2026 9:43 am
RARE Stock Down 46% as Phase III Angelman Syndrome Study Misses Goals - Sep 3rd, 2026 9:25 am